Aprea Therapeutics, Inc. APRE Q3 2025 earnings

FAQ

When did Aprea Therapeutics, Inc. report Q3 2025 earnings?

Aprea Therapeutics, Inc. (APRE) reported Q3 2025 earnings on November 12, 2025 before market open.

What were Aprea Therapeutics, Inc.'s Q3 2025 revenue and EPS?

Aprea Therapeutics, Inc. reported revenue of $1.8K and eps of $-0.47 for Q3 2025.

Did Aprea Therapeutics, Inc. beat estimates in Q3 2025?

EPS missed the consensus estimate of $-0.11 by $0.36.

How did Aprea Therapeutics, Inc.'s Q3 2025 results compare year-over-year?

Compared to the same quarter a year prior, revenue declined 99.5% from $354.6K a year earlier and eps grew 26.6% from $-0.64.

Where can I find Aprea Therapeutics, Inc.'s Q3 2025 SEC filings?

You can read the 8-K earnings release (0001104659-25-109860) and the 10-Q periodic report (0001104659-25-109867) directly on SEC EDGAR. The filing index links above go to sec.gov.